RBA keeps interest rates steady at 4.35%, while economists predict possible cut to 4.10% in 4Q24. Australian biotech companies should be in focus amid rate cut talks.
What is covered in the Full Insight:
Interest Rate Environment
Reserve Bank of Australia's Policy Outlook
U.S. Federal Reserve's stance
Profiles of Selected Australian Biotech Companies
Risks in Biotechnology Investment
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.